tiprankstipranks
Merrimack Pharmaceuticals Inc. (MACK)
NASDAQ:MACK
US Market

Merrimack Pharmaceuticals (MACK) Stock Price & Analysis

354 Followers

MACK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$11.53 - $15.89
Previous Close$14.72
Volume129.21K
Average Volume (3M)106.56K
Market Cap
$214.05M
Enterprise Value$195.18M
Total Cash (Recent Filing)$18.88M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-178.2
Beta1.85
May 09, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding14,516,170
10 Day Avg. Volume119,677
30 Day Avg. Volume106,557
Standard Deviation0.32
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)11.41
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-178.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-164.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

MACK FAQ

What was Merrimack Pharmaceuticals Inc.’s price range in the past 12 months?
Merrimack Pharmaceuticals Inc. lowest stock price was $11.53 and its highest was $15.89 in the past 12 months.
    What is Merrimack Pharmaceuticals Inc.’s market cap?
    Currently, no data Available
    When is Merrimack Pharmaceuticals Inc.’s upcoming earnings report date?
    Merrimack Pharmaceuticals Inc.’s upcoming earnings report date is May 09, 2024 which is in 42 days.
      How were Merrimack Pharmaceuticals Inc.’s earnings last quarter?
      Merrimack Pharmaceuticals Inc. released its earnings results on Mar 07, 2024. The company reported -$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.017.
        Is Merrimack Pharmaceuticals Inc. overvalued?
        According to Wall Street analysts Merrimack Pharmaceuticals Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Merrimack Pharmaceuticals Inc. pay dividends?
          Merrimack Pharmaceuticals Inc. pays a Notavailable dividend of $0.5 which represents an annual dividend yield of N/A. See more information on Merrimack Pharmaceuticals Inc. dividends here
            What is Merrimack Pharmaceuticals Inc.’s EPS estimate?
            Merrimack Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Merrimack Pharmaceuticals Inc. have?
            Merrimack Pharmaceuticals Inc. has 14,531,760 shares outstanding.
              What happened to Merrimack Pharmaceuticals Inc.’s price movement after its last earnings report?
              Merrimack Pharmaceuticals Inc. reported an EPS of -$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.339%.
                Which hedge fund is a major shareholder of Merrimack Pharmaceuticals Inc.?
                Among the largest hedge funds holding Merrimack Pharmaceuticals Inc.’s share is Western Standard Llc. It holds Merrimack Pharmaceuticals Inc.’s shares valued at 29M.
                  ---

                  Merrimack Pharmaceuticals Stock Smart Score

                  Company Description

                  Merrimack Pharmaceuticals Inc.

                  Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Advaxis
                  Corbus Pharmaceuticals
                  Agios Pharma
                  Akari Therapeutics
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis